Csírasejtes heredaganatok HER-2/neu-expressziójának klinikai jelento″sége

Translated title of the contribution: Clinical relevance of HER-2/neu expression in germ-cell testicular tumors

Mándoky László, L. Géczi, I. Bodrogi, J. Tóth, M. Bak

Research output: Contribution to journalArticle

Abstract

Amplification and/or overexpression of HER-2/neu are associated with poor clinical outcome in several epithelial tumours. The exact prognostic role of HER-2/neu expression in testicular germ-cell tumours is not well examined. Since teratomas are relatively chemoresistant tumors, we evaluated the HER-2/neu alterations of 59 primary testicular teratomas and mixed germ-cell tumours containing teratoma components using standardized immunohistochemical method (IHC) (HercepTest™) and Fluorescence in Situ Hybridization (FISH). HER-2/neu overexpression was detected in 14 (24%) of 59 specimens. With IHC, teratoma and choriocarcinoma components showed significantly higher HER-2/neu expression compared to other histological subtypes of GCTs (p=0.0095). A statistically significant correlation (p=0.0004) can be established between HER-2/neu status and clinical stage of the disease. Similarly, a significant correlation was observed between HER-2/neu overexpression and clinical outcome (p=0.0077). None of the specimens had definite HER-2/neu gene amplification. Our results suggest that HER-2/neu overexpression is associated with an adverse clinical outcome and has a prognostic role in testicular germ-cell tumours.

Original languageHungarian
Pages (from-to)143-150
Number of pages8
JournalMagyar Urologia
Volume16
Issue number3
Publication statusPublished - 2004

Fingerprint

Teratoma
erbB-2 Genes
Choriocarcinoma
Gene Amplification
Germ Cell and Embryonal Neoplasms
Fluorescence In Situ Hybridization
Neoplasms
Testicular Germ Cell Tumor

ASJC Scopus subject areas

  • Urology

Cite this

Csírasejtes heredaganatok HER-2/neu-expressziójának klinikai jelento″sége. / László, Mándoky; Géczi, L.; Bodrogi, I.; Tóth, J.; Bak, M.

In: Magyar Urologia, Vol. 16, No. 3, 2004, p. 143-150.

Research output: Contribution to journalArticle

@article{410e3afb12c14ef49c16e0391ab3fefc,
title = "Cs{\'i}rasejtes heredaganatok HER-2/neu-expresszi{\'o}j{\'a}nak klinikai jelento″s{\'e}ge",
abstract = "Amplification and/or overexpression of HER-2/neu are associated with poor clinical outcome in several epithelial tumours. The exact prognostic role of HER-2/neu expression in testicular germ-cell tumours is not well examined. Since teratomas are relatively chemoresistant tumors, we evaluated the HER-2/neu alterations of 59 primary testicular teratomas and mixed germ-cell tumours containing teratoma components using standardized immunohistochemical method (IHC) (HercepTest™) and Fluorescence in Situ Hybridization (FISH). HER-2/neu overexpression was detected in 14 (24{\%}) of 59 specimens. With IHC, teratoma and choriocarcinoma components showed significantly higher HER-2/neu expression compared to other histological subtypes of GCTs (p=0.0095). A statistically significant correlation (p=0.0004) can be established between HER-2/neu status and clinical stage of the disease. Similarly, a significant correlation was observed between HER-2/neu overexpression and clinical outcome (p=0.0077). None of the specimens had definite HER-2/neu gene amplification. Our results suggest that HER-2/neu overexpression is associated with an adverse clinical outcome and has a prognostic role in testicular germ-cell tumours.",
keywords = "FISH, Germ-cell testicular tumour, HER-2, Immunohistochemistry",
author = "M{\'a}ndoky L{\'a}szl{\'o} and L. G{\'e}czi and I. Bodrogi and J. T{\'o}th and M. Bak",
year = "2004",
language = "Hungarian",
volume = "16",
pages = "143--150",
journal = "Magyar Urologia",
issn = "0864-8921",
publisher = "Society of Hungarian Urological Surgeons",
number = "3",

}

TY - JOUR

T1 - Csírasejtes heredaganatok HER-2/neu-expressziójának klinikai jelento″sége

AU - László, Mándoky

AU - Géczi, L.

AU - Bodrogi, I.

AU - Tóth, J.

AU - Bak, M.

PY - 2004

Y1 - 2004

N2 - Amplification and/or overexpression of HER-2/neu are associated with poor clinical outcome in several epithelial tumours. The exact prognostic role of HER-2/neu expression in testicular germ-cell tumours is not well examined. Since teratomas are relatively chemoresistant tumors, we evaluated the HER-2/neu alterations of 59 primary testicular teratomas and mixed germ-cell tumours containing teratoma components using standardized immunohistochemical method (IHC) (HercepTest™) and Fluorescence in Situ Hybridization (FISH). HER-2/neu overexpression was detected in 14 (24%) of 59 specimens. With IHC, teratoma and choriocarcinoma components showed significantly higher HER-2/neu expression compared to other histological subtypes of GCTs (p=0.0095). A statistically significant correlation (p=0.0004) can be established between HER-2/neu status and clinical stage of the disease. Similarly, a significant correlation was observed between HER-2/neu overexpression and clinical outcome (p=0.0077). None of the specimens had definite HER-2/neu gene amplification. Our results suggest that HER-2/neu overexpression is associated with an adverse clinical outcome and has a prognostic role in testicular germ-cell tumours.

AB - Amplification and/or overexpression of HER-2/neu are associated with poor clinical outcome in several epithelial tumours. The exact prognostic role of HER-2/neu expression in testicular germ-cell tumours is not well examined. Since teratomas are relatively chemoresistant tumors, we evaluated the HER-2/neu alterations of 59 primary testicular teratomas and mixed germ-cell tumours containing teratoma components using standardized immunohistochemical method (IHC) (HercepTest™) and Fluorescence in Situ Hybridization (FISH). HER-2/neu overexpression was detected in 14 (24%) of 59 specimens. With IHC, teratoma and choriocarcinoma components showed significantly higher HER-2/neu expression compared to other histological subtypes of GCTs (p=0.0095). A statistically significant correlation (p=0.0004) can be established between HER-2/neu status and clinical stage of the disease. Similarly, a significant correlation was observed between HER-2/neu overexpression and clinical outcome (p=0.0077). None of the specimens had definite HER-2/neu gene amplification. Our results suggest that HER-2/neu overexpression is associated with an adverse clinical outcome and has a prognostic role in testicular germ-cell tumours.

KW - FISH

KW - Germ-cell testicular tumour

KW - HER-2

KW - Immunohistochemistry

UR - http://www.scopus.com/inward/record.url?scp=84866981638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866981638&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84866981638

VL - 16

SP - 143

EP - 150

JO - Magyar Urologia

JF - Magyar Urologia

SN - 0864-8921

IS - 3

ER -